Temperate Climate
Niche for
Cryptococcus gattii in Northern Europe
To the Editor: Cryptococcus gattii was considered to be geographically restricted to countries with tropical and subtropical climates until 1999, when an outbreak of cryptococcosis in humans and animals occurred in the temperate climate of Vancouver Island, British Columbia, Canada (1). Montagna et al. reported the fi rst environmental C. gattii in Europe from the Mediterranean region of Italy; these authors isolated it from 11 (4.3%) of 255 samples of plant detritus of Eucalyptus camaldulensis trees collected from the residential locality of an autochthonous case of cryptococcal meningitis caused by C. gattii in Apulia (2). These observations were recently substantiated by the isolation of C. gattii from plant debris of trees belonging to Ceratonia siliqua (carob), Pinus halepensis (stone pine), and E. camaldulensis in Spain (3). We report environmental isolation of the primary pathogenic fungus C. gattii from a forest in Berg en Dal, the Netherlands, which extends its geographic distribution to the temperate climate of northern Europe.
We investigated 112 decayed wood samples collected from inside trunk hollows of 52 living trees belonging to 5 families during April-May 2011 in Nijmegen, the Netherlands. The trees sampled were chestnut (Castanea sativa, n = 24), Douglas fi r (Pseudotsuga menziesii, n = 17), oak (Quercus macranthera, n = 6), walnut (Juglans regia, n = 3), and mulberry (Morus alba, n = 2). The main criterion in selecting a tree for sampling was advanced age and presence of large trunk hollows variably sheltered from sunlight. The sampled sites had no bird nests and were apparently free from avian excreta. The decayed wood samples were collected with an in-house swabbing technique by using simplifi ed Staib niger seed agar as described (4) . The plates were incubated at 30°C and periodically observed up to 7 days for isolation of C. gattii and C. neoformans. Suspected colonies of Cryptococcus spp. were purifi ed by dilution plating and identifi ed by their morphologic and biochemical profi les, including development of blue color on L-canavanine-glycine bromothymol blue medium.
Identity of the isolates was confi rmed by sequencing the internal trascribed spacer and D1/ D2 regions, and they were genotyped by using amplifi ed fragment-length polymorphism (AFLP) fi ngerprinting and multilocus sequence typing (MLST). The MLST loci CAP10, CAP59, GPD1, IGS, LAC1, MPD1, PLB1, SOD1, TEF1α, and URA5 of the environmental C. gattii isolates were amplifi ed and sequenced, and data were compared with MLST data from a large C. gattii population study (5) and with a recently published set of clinical, animal, and environmental C. gattii isolates from Mediterranean Europe and the Netherlands (Figure)  (3,6,7) . In addition, the mating type was determined with PCR by using mating type-specifi c primers for the STE12a and α alleles (8) .
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Four strains of C. neoformans species complex were isolated from the 112 decayed wood samples examined from 52 trees. One strain that originated from an oak tree (Q. macranthera), was identifi ed as C. neoformans var. grubii. The remaining 3 strains, all originating from different hollows in a Douglas fi r tree, were identifi ed as C. gattii genotype AFLP4/VGI and mating type α. The strains were deposited at the CBS-KNAW (Centraalbureau voor Schimmelcultures/Royal Netherlands Academy of Arts and Sciences) Fungal Biodiversity Centre (accession nos. CBS12349, CBS12355, and 12356), and the sequences were deposited in GenBank (accession nos. JN982044-JN982073).
MLST analysis showed that the C. gattii isolates in our study are more closely related to the clinical isolate from the Netherlands (6) and to the clinical and environmental C. gattii isolates (AFLP4/VGI) reported from the Netherlands and other countries in Europe than to isolates from outside Europe (3, 7, 8) . The autochthonous C. gattii AFLP4/VGI isolate, CBS2502 (earlier identifi ed as C. neoformans) isolate from the Netherlands was recovered postmortem in 1957 from the lungs of a pregnant woman with cryptococcosis (6) . This patient came from a low socioeconomic strata, was unlikely to have traveled outside the Netherlands, and probably acquired the infection indigenously from an environmental source (6) .
Furthermore, genotype AFLP4/ VGI appears to be the genotype of C. gattii prevalent in Europe (3, 7, 8) . Outside Europe, C. gattii has been reported from Douglas fi r trees in Vancouver Island, British Columbia, Canada; however, those isolates represented another molecular type, i.e., AFLP6/VGII (9). Genotype AFLP 4/VGI C. gattii isolates have been implicated in human infections in that region, but to our knowledge, no environmental isolates have been found until now.
Our detection of C. gattii in the environment and its previous isolation from a clinical case in the Netherlands suggests that this pathogen is endemic to the temperate climate of northern Europe. This suggestion agrees with the concept emerging from a decade of investigations in Canada and the Pacifi c Northwest that the geographic distribution of C. gattii extends to the temperate region, albeit with another AFLP genotype (1, 9, 10 Figure. Unrooted bootstrap maximum-likelihood phylogenetic multilocus sequence typing analysis of Cryptococcus gattii genotype AFLP4/VGI isolates based on 7 unlinked nuclear loci (5) . Bracket indicates the 3 C. gattii isolates from the Netherlands cultured from Douglas fi r (Pseudotsuga menziesii) (CBS12349, CBS12355, CBS12356) and 1 clinical isolate from 1957 from the Netherlands (CBS2502) (6) . Isolates in gray to the left of the bracket are the previously observed European Mediterranean cluster, with clinical, animal and environmental isolates (3) . All other C. gattii AFLP4/VGI isolates originate mainly from Australia, Africa, and South America, as described (5) . The isolates from the Netherlands are closely related to isolates that originated from the Mediterranean region. Numbers next to branches show bootstrap support (>80). A color version of this fi gure is available online (wwwnc.cdc.gov/EID/article/18/1/11-1190-F1.htm).
